Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Three Questions
Three Questions
RSS
Three Questions: Gary Palgon, Liaison Technologies
October 30, 2017
CenterWatch Staff
Three Questions: Shree Kalluri, Forte Research Systems
October 16, 2017
CenterWatch Staff
Three Questions: Iva Toudjarska, Halloran Consulting Group
October 2, 2017
CenterWatch Staff
Three Questions: Mitchell Katz, Purdue Pharma
September 18, 2017
CenterWatch Staff
Three Questions: Bill Row, Icon
September 1, 2017
CenterWatch Staff
Three Questions: Rob DiCicco, GlaxoSmithKline
August 21, 2017
CenterWatch Staff
Three Questions: Patrick Hughes, CluePoints
August 7, 2017
CenterWatch Staff
Three Questions: John Moore, Trialogics
July 24, 2017
CenterWatch Staff
Three Questions: Jim Kremidas, ACRP
July 10, 2017
CenterWatch Staff
Three Questions: Greg Ambra, DZS Clinical Services
June 26, 2017
CenterWatch Staff
Previous
1
2
3
4
5
6
Next
Upcoming Events
23
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here